ARTICLE | Product Development
Newco trend watch: Clusters of launches point to areas undergoing derisking
Oligo delivery to the kidney, and two emerging use cases for T cell engagers, each get newcos; most with mega-raises
October 22, 2024 9:18 PM UTC
Three sets of company launches spotlight emerging areas that groups of investors are seeing as safe to lean into.
Each trend is a case of matching a relatively established technology with a newer use case that builds on recent progress in a field, with companies proposing innovations they believe will maximize value. All six companies are taking a focused approach to applying a derisked therapeutic modality in a new context...
Get Unlimited Access
To view this item, login or register for a free account.
Or Purchase This ArticleBCIQ Company Profiles